The soluble guanylate cyclase activator cinaciguat prevents cardiac dysfunction in a rat model of type-1 diabetes mellitus
Diabetes mellitus (DM) leads to the development of diabetic cardiomyopathy, which is associated with altered nitric oxide (NO)—soluble guanylate cyclase (sGC)—cyclic guanosine monophosphate (cGMP) signalling. Cardioprotective effects of elevated intracellular cGMP-levels have been described in diffe...
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
31 October 2015
|
| In: |
Cardiovascular diabetology
Year: 2015, Volume: 14, Issue: 1 |
| ISSN: | 1475-2840 |
| DOI: | 10.1186/s12933-015-0309-x |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s12933-015-0309-x |
| Author Notes: | Csaba Mátyás, Balázs Tamás Németh, Attila Oláh, László Hidi, Ede Birtalan, Dalma Kellermayer, Mihály Ruppert, Sevil Korkmaz-Icöz, Gábor Kökény, Eszter Mária Horváth, Gábor Szabó, Béla Merkely and Tamás Radovits |
Search Result 1
The soluble guanylate cyclase activator cinaciguat prevents cardiac dysfunction in a rat model of type-1 diabetes mellitus
BioMed Central 2016
Article (Journal)
Book/Monograph
Online Resource